36 results match your criteria: "Columbia University and the New York Presbyterian Hospital[Affiliation]"

Intact global cognitive and olfactory ability predicts lack of transition to dementia.

Alzheimers Dement

February 2020

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Introduction: Odor identification deficits characterize Alzheimer's disease and other dementias. We examined if intact performance on brief cognitive and odor identification tests predicts lack of transition to dementia.

Methods: In an urban community, 1037 older adults without dementia completed the 40-item University of Pennsylvania Smell Identification Test, which includes the 12-item Brief Smell Identification Test (B-SIT).

View Article and Find Full Text PDF

Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.

Brain

November 2019

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave, Toronto, ON, Canada.

Age at onset of Alzheimer's disease is highly variable, and its modifiers (genetic or environmental) could act through epigenetic changes, such as DNA methylation at CpG sites. DNA methylation is also linked to ageing-the strongest Alzheimer's disease risk factor. DNA methylation age can be calculated using age-related CpGs and might reflect biological ageing.

View Article and Find Full Text PDF

Genomic variation in educational attainment modifies Alzheimer disease risk.

Neurol Genet

April 2019

The Gertrude H. Sergievsky Center (N.S.R., B.V.), Columbia University; The Institute for Genomic Medicine (N.S.R.), Columbia University; The Taub Institute for Research in Alzheimer's Disease and the Aging Brain (B.V.), Columbia University; The Department of Neurology (R.M.), Columbia University and The New York Presbyterian Hospital; The Department of Epidemiology (R.M.), Joseph P. Mailman School of Public Health, Columbia University, New York, NY.

Objective: To determine the putative protective relationship of educational attainment on Alzheimer disease (AD) risk using Mendelian randomization and to test the hypothesis that by using genetic regions surrounding individually associated single nucleotide polymorphisms (SNPs) as the instrumental variable, we can identify genes that contribute to the relationship.

Methods: We performed Mendelian randomization using genome-wide association study summary statistics from studies of educational attainment and AD in two stages. Our instrumental variable comprised (1) 1,271 SNPs significantly associated with educational attainment and (2) individual 2-Mb regions surrounding the genome-wide significant SNPs.

View Article and Find Full Text PDF

Circulating inflammatory biomarkers are related to cerebrovascular disease in older adults.

Neurol Neuroimmunol Neuroinflamm

January 2019

Taub Institute for Research in Alzheimer's Disease and the Aging Brain (Y.G., I.B.M., V.A.G., J.J.M., N.S., A.M.B., R.M.), Columbia University; Department of Neurology (Y.G., J.G., J.J.M., N.S., A.M.B., R.M.), Columbia University and the New York Presbyterian Hospital; Department of Epidemiology (Y.G., N.S., R.M.), Joseph P. Mailman School of Public Health, Columbia University; and the Gertrude H. Sergievsky Center (Y.G., J.J.M., A.M.B., R.M.), Columbia University, New York.

Objective: This investigation aimed at examining whether circulating inflammatory biomarkers C-reactive protein (CRP), interleukin-6 (IL6), and alpha 1-antichymotrypsin (ACT) were related to cerebrovascular disease (CVD) assessed by MRI.

Methods: The study included nondemented elderly participants of a community-based, multiethnic cohort, who received baseline MRI scans and had CRP (n = 508), ACT (435), and IL6 (N = 357) measured by ELISA. Silent brain infarcts and white matter hyperintensities (WMH) were derived from all available MRI scans at baseline, approximately 4.

View Article and Find Full Text PDF

Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.

J Alzheimers Dis

August 2019

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Background: Elevated total tau (tTau), 181-phosphorylated phosphorylated tau (pTau), and low amyloid-β42 (Aβ42) in cerebrospinal fluid (CSF) represent a diagnostic biomarker for Alzheimer's disease (AD).

Objective: The goal was to determine the overall accuracy of CSF Aβ42, tTau, pTau, and the Aβ42/total tau index (ATI) in a non-research, clinical setting for the diagnosis of AD.

Methods: From medical records in 1,016 patients that had CSF studies for dementia over a 12-year period (2005 to 2017), we calculated the sensitivity and specificity of CSF Aβ42, tTau, and pTau and the ATI in relation to the final clinical diagnosis.

View Article and Find Full Text PDF

Pattern of extrapyramidal signs in Alzheimer's disease.

J Neurol

November 2015

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.

Patients with Alzheimer's disease (AD) often develop extrapyramidal signs (EPS), which increase in frequency as the disease progresses. We aimed to investigate the patterns of presentation of EPS in AD and their correlation with clinical and neuropathological features. 4284 subjects diagnosed with AD from the National Alzheimer's Coordinating Center (NACC) database with at least one abnormal Unified Parkinson's Disease Rating Scale (UPDRS) assessment were included.

View Article and Find Full Text PDF

Importance: There have been recent calls for increased access to mental health services, but access may be limited owing to psychiatrist refusal to accept insurance.

Objective: To describe recent trends in acceptance of insurance by psychiatrists compared with physicians in other specialties.

Design, Setting, And Participants: We used data from a national survey of office-based physicians in the United States to calculate rates of acceptance of private noncapitated insurance, Medicare, and Medicaid by psychiatrists vs physicians in other specialties and to compare characteristics of psychiatrists who accepted insurance and those who did not.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is the most common tachyarrhythmia encountered by clinicians. When AF occurs in patients with structural disorders, hypertension is most common. Hypertension may provoke or enable AF to occur through several mechanisms.

View Article and Find Full Text PDF

Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias.

Am J Cardiol

May 2000

The Electrophysiology Service, Division of Cardiology, Department of Medicine, Columbia University and The New York Presbyterian Hospital, New York, NY, USA.

The consequences of antiarrhythmic drug formulation substitution were assessed by survey of 130 experts on arrhythmias. Fifty-four arrhythmia recurrences, 7 proarrhythmic events, and 3 deaths resulting from generic substitution are reported, thus raising serious concerns about both antiarrhythmic drug substitution and the adequacy of the generic drug approval process.

View Article and Find Full Text PDF

It has been reasonably well documented that a pregnant resident physician can assume radiology rotations, including higher-exposure rotations such as angiography and nuclear medicine, without exposing the fetus to radiation levels that exceed national and international guidelines. Hence, many medical physicists support the contention that rotations should not be altered because a resident is pregnant. On the other hand, many if not most physicists subscribe to the ALARA (as low as reasonably achievable) principle, especially in cases of fetal exposure where increased radiation susceptibility is combined with an inability to decide for one-self.

View Article and Find Full Text PDF